Brief: Altamira Therapeutics Files Prospectus Relates To Disposition From Time To Time Of Up To 2.8 Mln Common Shares By Selling Shareholder
14/04/2022 22:10
April 14 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS FILES PROSPECTUS RELATES TO
DISPOSITION
FROM TIME TO TIME OF UP TO 2.8 MILLION COMMON SHARES BY SELLING
SHAREHOLDER
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering